Kafkas J Med Sci. 2019; 9(1): 11-16 | DOI: 10.5505/kjms.2019.96977 | |||
Transüretral Prostat Rezeksiyonu Materyallerindeki İnsidental Kanser Sıklığı ve Bu Hastalardaki Klinik Yaklaşımımız; Geriye Dönük Dosya TaramasıCaner Özbey1, Kenan Öztorun21Niğde Ömer Halisdemir Üniversitesi, Tıp Fakültesi, Patoloji AD2Niğde Ömer Halisdemir Üniversitesi Tıp Fakültesi Üroloji AD Amaç: Çalışma, Niğde Ömer Halisdemir Üniversitesi Eğitim ve Araştırma Hastanesi (EAH)’nde mesane çıkış obstrüksiyonu nedeniyle transüretral prostat rezeksiyonu (TUR-P) uygulanan hastalardaki kanser sıklığını belirlemek ve bu hastalardaki klinik yaklaşımımızı paylaşmayı amaçlamaktadır. Frequency of Incidental Cancer in Transurethral Prostate Resection Materials and Our Clinical Approach to These Patients; a Retrospective File ScanCaner Özbey1, Kenan Öztorun21Niğde Ömer Halisdemir University, Faculty of Medicine, Department of Pathology2Niğde Ömer Halisdemir University, Faculty of Medicine, Department of Urology, Niğde, Turkey Aim: This study aims to determine the incidence of cancer in patients who underwent transurethral resection of the prostate (TUR-P) due to bladder outlet obstruction and to share our clinical approach to these patients at Niğde Ömer Halisdemir University Training and Research Hospital. Material and Method: The pathology reports of 650 TUR-P specimens from January 1, 2012, to December 31, 2017, were retrospectively screened. In the pathology results of the prostatic adenocarcinoma patients, the age, tumor stage and Gleason score (GS) were evaluated. Physical examination data and the serum total Prostate Specific Antigen (PSA) levels, as well as the radiological findings, were analyzed according to the hospital records. Results: After excluding nine patients with known prostate carcinoma there were 15 adenocarcinomas out of 641 patients (2.34%). The mean age was 72. Eleven patients were diagnosed as GS 6, and four patients were diagnosed with GS 7 prostate adenocarcinoma. Serum total PSA levels ranged from 1.56 to 9.22 ng/mL. T1a tumor was detected in 11 patients and T1b tumor in 4 patients. Conclusion: Considering the studies that reported incidental prostate cancer (IPC) rates in the PSA era, our rate is close to the lower limit. The application of primary therapies should not be avoided in patients with IPC after TUR-P. Keywords: incidental prostate cancer, transurethral resection; PSACaner Özbey, Kenan Öztorun. Frequency of Incidental Cancer in Transurethral Prostate Resection Materials and Our Clinical Approach to These Patients; a Retrospective File Scan. Kafkas J Med Sci. 2019; 9(1): 11-16 Sorumlu Yazar: Caner Özbey, Türkiye |
|
Bu eser Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Kafkas Üniversitesi Tıp Fakültesi Dekanlığı
Kafkas Tıp Bilimleri Dergisi Editörlüğü
Kars, Türkiye
Telefon: +90 474 225 11 92 - 93 Faks: +90 474 225 11 96
e-mail: edit.tipdergi@gmail.com